PMC:7166305 / 9100-10062 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T43","span":{"begin":18,"end":21},"obj":"Body_part"},{"id":"T44","span":{"begin":27,"end":30},"obj":"Body_part"},{"id":"T45","span":{"begin":159,"end":162},"obj":"Body_part"},{"id":"T46","span":{"begin":164,"end":167},"obj":"Body_part"},{"id":"T47","span":{"begin":871,"end":874},"obj":"Body_part"},{"id":"T48","span":{"begin":880,"end":883},"obj":"Body_part"}],"attributes":[{"id":"A43","pred":"fma_id","subj":"T43","obj":"http://purl.org/sig/ont/fma/fma63170"},{"id":"A44","pred":"fma_id","subj":"T44","obj":"http://purl.org/sig/ont/fma/fma63171"},{"id":"A45","pred":"fma_id","subj":"T45","obj":"http://purl.org/sig/ont/fma/fma63170"},{"id":"A46","pred":"fma_id","subj":"T46","obj":"http://purl.org/sig/ont/fma/fma63171"},{"id":"A47","pred":"fma_id","subj":"T47","obj":"http://purl.org/sig/ont/fma/fma63170"},{"id":"A48","pred":"fma_id","subj":"T48","obj":"http://purl.org/sig/ont/fma/fma63171"}],"text":"Ratio changes for LDL (A), HDL (B) and TC (C) in COVID-19 patients during the course of disease. For each data point, the ratio is normalized to the levels of LDL, HDL and TC prior to infection for the same patient. The days listed are the duration (median (IQR)) for each period during the disease course. The date on admission is set as “day 0”. Data is presented as “mean ± 95% confidence interval”. # indicates p \u003c 0.05 as compared to the levels of pre-infection stage, and * indicates p \u003c 0.05 as compared to the levels on admission, by a Mann-Whitney U test. The sample actual values at each stage are listed in Supplementary Table S1. The ratios of hsCRP at each time point are normalized to the levels prior to infection in the same patients. Pearson correlation coefficient analysis show the ratios of hsCRP significantly inversely correlated with the ratios of LDL (D), HDL (E) and TC (F) during the disease course; n = 33 data pairs for each analysis."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T55","span":{"begin":49,"end":57},"obj":"Disease"},{"id":"T56","span":{"begin":184,"end":193},"obj":"Disease"},{"id":"T57","span":{"begin":457,"end":466},"obj":"Disease"},{"id":"T58","span":{"begin":719,"end":728},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A56","pred":"mondo_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A57","pred":"mondo_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Ratio changes for LDL (A), HDL (B) and TC (C) in COVID-19 patients during the course of disease. For each data point, the ratio is normalized to the levels of LDL, HDL and TC prior to infection for the same patient. The days listed are the duration (median (IQR)) for each period during the disease course. The date on admission is set as “day 0”. Data is presented as “mean ± 95% confidence interval”. # indicates p \u003c 0.05 as compared to the levels of pre-infection stage, and * indicates p \u003c 0.05 as compared to the levels on admission, by a Mann-Whitney U test. The sample actual values at each stage are listed in Supplementary Table S1. The ratios of hsCRP at each time point are normalized to the levels prior to infection in the same patients. Pearson correlation coefficient analysis show the ratios of hsCRP significantly inversely correlated with the ratios of LDL (D), HDL (E) and TC (F) during the disease course; n = 33 data pairs for each analysis."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T84","span":{"begin":23,"end":24},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T85","span":{"begin":32,"end":33},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T86","span":{"begin":542,"end":543},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T87","span":{"begin":559,"end":563},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T88","span":{"begin":638,"end":640},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"}],"text":"Ratio changes for LDL (A), HDL (B) and TC (C) in COVID-19 patients during the course of disease. For each data point, the ratio is normalized to the levels of LDL, HDL and TC prior to infection for the same patient. The days listed are the duration (median (IQR)) for each period during the disease course. The date on admission is set as “day 0”. Data is presented as “mean ± 95% confidence interval”. # indicates p \u003c 0.05 as compared to the levels of pre-infection stage, and * indicates p \u003c 0.05 as compared to the levels on admission, by a Mann-Whitney U test. The sample actual values at each stage are listed in Supplementary Table S1. The ratios of hsCRP at each time point are normalized to the levels prior to infection in the same patients. Pearson correlation coefficient analysis show the ratios of hsCRP significantly inversely correlated with the ratios of LDL (D), HDL (E) and TC (F) during the disease course; n = 33 data pairs for each analysis."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T52","span":{"begin":18,"end":21},"obj":"Chemical"},{"id":"T53","span":{"begin":27,"end":30},"obj":"Chemical"},{"id":"T54","span":{"begin":159,"end":162},"obj":"Chemical"},{"id":"T55","span":{"begin":164,"end":167},"obj":"Chemical"},{"id":"T56","span":{"begin":871,"end":874},"obj":"Chemical"},{"id":"T57","span":{"begin":880,"end":883},"obj":"Chemical"}],"attributes":[{"id":"A52","pred":"chebi_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/CHEBI_39026"},{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_39025"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_39026"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_39025"},{"id":"A56","pred":"chebi_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/CHEBI_39026"},{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_39025"}],"text":"Ratio changes for LDL (A), HDL (B) and TC (C) in COVID-19 patients during the course of disease. For each data point, the ratio is normalized to the levels of LDL, HDL and TC prior to infection for the same patient. The days listed are the duration (median (IQR)) for each period during the disease course. The date on admission is set as “day 0”. Data is presented as “mean ± 95% confidence interval”. # indicates p \u003c 0.05 as compared to the levels of pre-infection stage, and * indicates p \u003c 0.05 as compared to the levels on admission, by a Mann-Whitney U test. The sample actual values at each stage are listed in Supplementary Table S1. The ratios of hsCRP at each time point are normalized to the levels prior to infection in the same patients. Pearson correlation coefficient analysis show the ratios of hsCRP significantly inversely correlated with the ratios of LDL (D), HDL (E) and TC (F) during the disease course; n = 33 data pairs for each analysis."}

{"project":"LitCovid-sentences","denotations":[{"id":"T117","span":{"begin":97,"end":215},"obj":"Sentence"},{"id":"T118","span":{"begin":216,"end":306},"obj":"Sentence"},{"id":"T119","span":{"begin":307,"end":347},"obj":"Sentence"},{"id":"T120","span":{"begin":348,"end":564},"obj":"Sentence"},{"id":"T121","span":{"begin":565,"end":641},"obj":"Sentence"},{"id":"T122","span":{"begin":642,"end":750},"obj":"Sentence"},{"id":"T123","span":{"begin":751,"end":962},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ratio changes for LDL (A), HDL (B) and TC (C) in COVID-19 patients during the course of disease. For each data point, the ratio is normalized to the levels of LDL, HDL and TC prior to infection for the same patient. The days listed are the duration (median (IQR)) for each period during the disease course. The date on admission is set as “day 0”. Data is presented as “mean ± 95% confidence interval”. # indicates p \u003c 0.05 as compared to the levels of pre-infection stage, and * indicates p \u003c 0.05 as compared to the levels on admission, by a Mann-Whitney U test. The sample actual values at each stage are listed in Supplementary Table S1. The ratios of hsCRP at each time point are normalized to the levels prior to infection in the same patients. Pearson correlation coefficient analysis show the ratios of hsCRP significantly inversely correlated with the ratios of LDL (D), HDL (E) and TC (F) during the disease course; n = 33 data pairs for each analysis."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T76","span":{"begin":49,"end":57},"obj":"SP_7"},{"id":"T77","span":{"begin":49,"end":57},"obj":"SP_7"}],"text":"Ratio changes for LDL (A), HDL (B) and TC (C) in COVID-19 patients during the course of disease. For each data point, the ratio is normalized to the levels of LDL, HDL and TC prior to infection for the same patient. The days listed are the duration (median (IQR)) for each period during the disease course. The date on admission is set as “day 0”. Data is presented as “mean ± 95% confidence interval”. # indicates p \u003c 0.05 as compared to the levels of pre-infection stage, and * indicates p \u003c 0.05 as compared to the levels on admission, by a Mann-Whitney U test. The sample actual values at each stage are listed in Supplementary Table S1. The ratios of hsCRP at each time point are normalized to the levels prior to infection in the same patients. Pearson correlation coefficient analysis show the ratios of hsCRP significantly inversely correlated with the ratios of LDL (D), HDL (E) and TC (F) during the disease course; n = 33 data pairs for each analysis."}

{"project":"LitCovid-PubTator","denotations":[{"id":"210","span":{"begin":58,"end":66},"obj":"Species"},{"id":"211","span":{"begin":207,"end":214},"obj":"Species"},{"id":"212","span":{"begin":741,"end":749},"obj":"Species"},{"id":"213","span":{"begin":39,"end":41},"obj":"Chemical"},{"id":"214","span":{"begin":172,"end":174},"obj":"Chemical"},{"id":"215","span":{"begin":892,"end":894},"obj":"Chemical"},{"id":"216","span":{"begin":49,"end":57},"obj":"Disease"},{"id":"217","span":{"begin":184,"end":193},"obj":"Disease"},{"id":"218","span":{"begin":457,"end":466},"obj":"Disease"},{"id":"219","span":{"begin":719,"end":728},"obj":"Disease"}],"attributes":[{"id":"A210","pred":"tao:has_database_id","subj":"210","obj":"Tax:9606"},{"id":"A211","pred":"tao:has_database_id","subj":"211","obj":"Tax:9606"},{"id":"A212","pred":"tao:has_database_id","subj":"212","obj":"Tax:9606"},{"id":"A216","pred":"tao:has_database_id","subj":"216","obj":"MESH:C000657245"},{"id":"A217","pred":"tao:has_database_id","subj":"217","obj":"MESH:D007239"},{"id":"A218","pred":"tao:has_database_id","subj":"218","obj":"MESH:D007239"},{"id":"A219","pred":"tao:has_database_id","subj":"219","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ratio changes for LDL (A), HDL (B) and TC (C) in COVID-19 patients during the course of disease. For each data point, the ratio is normalized to the levels of LDL, HDL and TC prior to infection for the same patient. The days listed are the duration (median (IQR)) for each period during the disease course. The date on admission is set as “day 0”. Data is presented as “mean ± 95% confidence interval”. # indicates p \u003c 0.05 as compared to the levels of pre-infection stage, and * indicates p \u003c 0.05 as compared to the levels on admission, by a Mann-Whitney U test. The sample actual values at each stage are listed in Supplementary Table S1. The ratios of hsCRP at each time point are normalized to the levels prior to infection in the same patients. Pearson correlation coefficient analysis show the ratios of hsCRP significantly inversely correlated with the ratios of LDL (D), HDL (E) and TC (F) during the disease course; n = 33 data pairs for each analysis."}